{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:33:37Z","timestamp":1761284017593,"version":"build-2065373602"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    This case report explores a unique presentation of macrophage activating syndrome (MAS) as well as multisystem inflammatory syndrome in children (MIS-C), a complication of COVID-19, that was characterized by polyserositis with massive pleural effusions and edema. A 12-year-old girl had cervical pyogenic lymphadenitis, dyspnea, and cough in addition to the bilateral conjunctivitis, facial edema, erythema on both cheeks, and edema in the extremities. Initial laboratory investigations revealed a white blood cell count of 5.8\u2009\u00d7\u200910\n                    <jats:sup>9<\/jats:sup>\n                    \/L, hemoglobin 9.7\u2005g\/dl, platelet count 75\u2009\u00d7\u200910\n                    <jats:sup>9<\/jats:sup>\n                    \/L, C-reactive protein level 149\u2005mg\/L, serum aspartate aminotransferase 73\u2005U\/L, alanine aminotransferase 64\u2005U\/L, fibrinogen 446\u2005mg\/dl. The dyspnea and cough rapidly worsened and a chest x-ray demonstrated massive plural effusions bilaterally. An echocardiographic study showed slight pericardial effusion and a normal cardiac ejection fraction. Her condition, fever, high serum triglyceride, high serum ferritin level, hemophagocytosis, low NK cell activity, and high serum soluble IL-2R level were attributed to MAS. We started intravenous administration of prednisolone (2\u2005mg\/kg). The respiratory distress and pleural effusions showed little change 2 days after starting prednisolone, so we added oral cyclosporine (5\u2005mg\/kg\/day) based on the HLH-2004 protocol. Soon after starting cyclosporine, the respiratory distress and oxygenation improved and the pleural effusions significantly decreased. One month before admission, the patient's mother had fever and respiratory distress due to PCR-confirmed SARS-CoV-2 infection during the omicron variant wave in Japan. At that time, the patient also had fever. SARS-CoV-2 titers were subsequently tested, revealing that both anti-N antibodies and anti-S protein antibodies were positive. In 2021, there are few patients with COVID-19 in Japan, so the antibody titers were an important diagnostic tool in this period. Taking together these findings, we diagnosed her condition as MIS-C. The case highlights the complex overlap between MIS-C and MAS, with immunosuppressive therapy, particularly cyclosporine, playing a critical role in the management of severe cases.\n                  <\/jats:p>","DOI":"10.3389\/fped.2025.1633264","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:27:39Z","timestamp":1761283659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Rapidly progressive bilateral pleural effusions in a 12-year-old girl with multisystem inflammatory syndrome who was successfully treated with prednisolone and cyclosporine"],"prefix":"10.3389","volume":"13","author":[{"given":"Takeshi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Okunushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koo","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomozumi","family":"Takatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"year":"","key":"B1","article-title":"Centers of disease control and prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection 2023 Case Definition"},{"year":"","key":"B2","article-title":"WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2024066780","DOI":"10.1542\/peds.2024-066780","article-title":"Macrophage activation syndrome in MIS-C","volume":"154","author":"G\u00e1mez-Gonz\u00e1lez","year":"2024","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e13900","DOI":"10.1111\/pai.13900","article-title":"Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI position paper","volume":"34","author":"Feleszko","year":"2023","journal-title":"Pediatr Allergy Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"110252","DOI":"10.1016\/j.clim.2024.110252","article-title":"Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children","volume":"264","author":"Tulling","year":"2024","journal-title":"Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/children9070931","article-title":"Lung ultrasound patterns in multisystem inflammatory syndrome in children (MIS-C)-characteristics and prognostic value","volume":"21","author":"Camporesi","year":"2022","journal-title":"Children"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/jcm12082850","article-title":"Role of lung ultrasonography (LUS) as a tool for evaluating children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS)","volume":"12","author":"Tomczonek-Moru\u015b","year":"2023","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S2352-4642(23)00078-0","article-title":"Safety and effectiveness of vaccines against COVID-19 in children aged 5\u201311 years: a systematic review and meta-analysis","volume":"6","author":"Piechotta","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00246-022-02851-x","article-title":"Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination","volume":"43","author":"Chin","year":"2022","journal-title":"Pedatr Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","article-title":"Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association","volume":"150","author":"Jone","year":"2024","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1007\/s00431-024-05586-4","article-title":"Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study","volume":"183","author":"Schwartz","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/INF.0000000000003449","article-title":"Distinguishing multisystem inflammatory syndrome in children from COVID-19, kawasaki disease and toxic shock syndrome","volume":"41","author":"Godfred-Cato","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1017\/S1047951122002748","article-title":"Cyclosporin for treatment of refractory multisystemic inflammatory syndrome in a child","volume":"33","author":"G\u00e1mez-Gonz\u00e1lez","year":"2023","journal-title":"Cardiol Young"},{"key":"B18","doi-asserted-by":"publisher","first-page":"890755","DOI":"10.3389\/fped.2022.890755","article-title":"Case report: ciclosporin A for refractory multisystem inflammatory syndrome in children","volume":"31","author":"Suzuki","year":"2022","journal-title":"Front Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S2352-4642(23)00020-2","article-title":"Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial","volume":"4","author":"Welzel","year":"2023","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1633264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:27:40Z","timestamp":1761283660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1633264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":19,"alternative-id":["10.3389\/fped.2025.1633264"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1633264","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1633264"}}